RxDoctor Payments Data

Eric Holender, DO

Otology & Neurotology · Palmerton, PANPI 1992768543

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 90 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 20.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $825, more than ten times the $63 reported in 2019.

$2,216in general payments, 2019–2025

Across 90 payments — averaging $24.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$449
  • Sanofi$415
  • Inspire Medical Systems, Inc.$292
  • Neurent Medical Limited$216
  • Aerin Medical Inc.$203
  • Optinose US, Inc.$191
  • plus $449 from 12 others

What the payments were for

  • Food & beverage$2,216100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few otology & neurotology providers in Pennsylvaniato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$470,184
Medicare patients
1,855
Services billed
7,573

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl234$5,874
Ipratropium Bromide130$2,971
Fluticasone Propionate190$2,318
Mometasone Furoate24$891
Ofloxacin72$850
Montelukast Sodium31$586
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav30$279
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen53$233
Levocetirizine Dihydrochloride13$224
Prednisone43$123
Cephalexin27$69
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim13$66

Paid to pharmacies, not to this prescriber.

Other otology & neurotology in Palmerton

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →